logo
Plus   Neg
Share
Email

CytomX Therapeutics Holding On To Strong Gain In Late-Day Trading

Shares of CytomX Therapeutics (CTMX) have pulled back off their highs of the session but continue to significant strength in late-day trading on Wednesday. After reaching its best intraday level in well over a year, CytomX is currently up by 20.5 percent.

The jump by CytomX comes after the biopharmaceutical company announced it has entered into a strategic collaboration with Amgen (AMGN) in immuno-oncology.

by RTTNews Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Nike Inc. (NKE), the world's largest athletic shoes and apparel maker, Tuesday reported a first-quarter profit that increased from a year ago and trumped Wall Street estimates, driven largely by more-than-expected revenues and strong margins. Beaverton, Oregon-based Nike's first-quarter profit rose... German auto giant BMW (BMW.L, BAMXF.PK, BAMXY.PK) Tuesday lowered its earnings and revenue guidance for the full year 2018, hurt largely by emissions-related costs, product recalls and ongoing global trade war. Automotive segment revenues are now expected to be slightly lower than the previous year.... Walt Disney World is introducing a new ticket pricing system in order to better distribute attendance at its theme parks throughout the year. The company plans to begin pricing tickets for its theme parks based on dates so as to reflect the expected demand on specific days. Disney said Monday that beginning October 16, guests will be able to access its new online vacation-booking portal.
Follow RTT